A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
Stopped early · Phase 3
Conditions studied: Transplanted Organ Rejection
In brief
A randomized controlled study to evaluate the safety, efficacy, and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.
Key facts
- Study ID
- NCT03995901
- Run by
- Talaris Therapeutics Inc.
- People needed
- 15
- Starts
- 2019-10-25
- Expected to finish
- 2023-02-16
- Last updated by the study team
- 2023-03-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Phoenix, Arizona, United States
- Scripps Clinic — La Jolla, California, United States
- University of California, San Francisco — San Francisco, California, United States
- Georgetown University Hospital — Washington D.C., District of Columbia, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Northwestern Memorial Hospital — Chicago, Illinois, United States
- The University of Michigan Hospitals & Health System — Ann Arbor, Michigan, United States
- University of Minnesota Medical Center — Minneapolis, Minnesota, United States
- Mayo Clinic — Rochester, Minnesota, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- New York-Presbyterian/Weill Cornell — New York, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- The Ohio State University Wexner Medical Center — Columbus, Ohio, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Baylor University Medical Center — Dallas, Texas, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.